{"id": "399872", "url": "https://fevir.net/resources/Composition/399872", "date": "2025-12-11T20:35:21.032Z", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/baseline-measure-report"], "versionId": "5", "lastUpdated": "2025-12-11T20:35:21.032Z"}, "type": {"text": "Baseline Measure Report", "coding": [{"code": "BaselineMeasureReport", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "BaselineMeasureReport"}]}, "title": "Baseline Characteristics Report for NCT03421379", "author": [{"display": "[No author listed.]"}], "status": "final", "contained": [{"id": "NCT03421379-BaselineMeasure-0", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"]}, "title": "Age, Continuous", "status": "active", "timing": {"offsetDuration": {"value": 0}}, "classifier": [{"text": "Baseline Measure"}], "definition": {"concept": {"text": "Age, Continuous"}}, "resourceType": "EvidenceVariable", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail", "valueCodeableConcept": {"coding": [{"code": "evidence-variable-handling-not-specified", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Evidence variable handling not specified"}]}}], "handling": "extension"}, {"id": "NCT03421379-BaselineMeasure-1", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"]}, "title": "Sex: Female, Male", "status": "active", "timing": {"offsetDuration": {"value": 0}}, "category": [{"name": "Female"}, {"name": "Male"}], "classifier": [{"text": "Baseline Measure"}], "definition": {"concept": {"text": "Sex: Female, Male"}}, "resourceType": "EvidenceVariable", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail", "valueCodeableConcept": {"coding": [{"code": "evidence-variable-handling-not-specified", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Evidence variable handling not specified"}]}}], "handling": "extension"}, {"id": "NCT03421379-BaselineMeasure-2", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"]}, "title": "Ethnicity (NIH/OMB)", "status": "active", "timing": {"offsetDuration": {"value": 0}}, "category": [{"name": "Hispanic or Latino"}, {"name": "Not Hispanic or Latino"}, {"name": "Unknown or Not Reported"}], "classifier": [{"text": "Baseline Measure"}], "definition": {"concept": {"text": "Ethnicity (NIH/OMB)"}}, "resourceType": "EvidenceVariable", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail", "valueCodeableConcept": {"coding": [{"code": "evidence-variable-handling-not-specified", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Evidence variable handling not specified"}]}}], "handling": "extension"}, {"id": "NCT03421379-BaselineMeasure-3", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"]}, "title": "Race (NIH/OMB)", "status": "active", "timing": {"offsetDuration": {"value": 0}}, "category": [{"name": "American Indian or Alaska Native"}, {"name": "Asian"}, {"name": "Native Hawaiian or Other Pacific Islander"}, {"name": "Black or African American"}, {"name": "White"}, {"name": "More than one race"}, {"name": "Unknown or Not Reported"}], "classifier": [{"text": "Baseline Measure"}], "definition": {"concept": {"text": "Race (NIH/OMB)"}}, "resourceType": "EvidenceVariable", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail", "valueCodeableConcept": {"coding": [{"code": "evidence-variable-handling-not-specified", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Evidence variable handling not specified"}]}}], "handling": "extension"}, {"id": "NCT03421379-BaselineMeasure-4", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"]}, "title": "Region of Enrollment", "status": "active", "timing": {"offsetDuration": {"value": 0}}, "category": [{"name": "Japan"}], "classifier": [{"text": "Baseline Measure"}], "definition": {"concept": {"text": "Region of Enrollment"}}, "resourceType": "EvidenceVariable", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-handling-detail", "valueCodeableConcept": {"coding": [{"code": "evidence-variable-handling-not-specified", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Evidence variable handling not specified"}]}}], "handling": "extension"}, {"id": "BG000", "code": {"text": "Participants"}, "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"]}, "name": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution", "type": "person", "quantity": 33, "membership": "enumerated", "description": "A single dose of 3 mg glucagon nasal powder was administered intranasally", "resourceType": "Group", "characteristic": [{"code": {"text": "Research Study from which this is a baseline group"}, "exclude": false, "valueReference": {"display": "NCT03421379"}}]}, {"id": "BG001", "code": {"text": "Participants"}, "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"]}, "name": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder", "type": "person", "quantity": 39, "membership": "enumerated", "description": "A single dose of 1 mg glucagon hydrochloride solution was administered IM", "resourceType": "Group", "characteristic": [{"code": {"text": "Research Study from which this is a baseline group"}, "exclude": false, "valueReference": {"display": "NCT03421379"}}]}, {"id": "BG002", "code": {"text": "Participants"}, "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"]}, "name": "Total", "type": "person", "quantity": 72, "membership": "enumerated", "description": "Total of all reporting groups", "resourceType": "Group", "characteristic": [{"code": {"text": "Research Study from which this is a baseline group"}, "exclude": false, "valueReference": {"display": "NCT03421379"}}]}, {"id": "NCT03421379-BaselineMeasure-0-BG000", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_0_BG000", "title": "Age, Continuous for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "status": "active", "statistic": [{"quantity": {"unit": "years", "value": 41.7}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"coding": [{"code": "STATO:0000573", "system": "https://fevir.net/sevco", "display": "mean"}]}, "attributeEstimate": [{"type": {"text": "Standard Deviation"}, "quantity": {"unit": "years", "value": 11.6}}]}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution", "reference": "#BG000"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Age, Continuous", "reference": "#NCT03421379-BaselineMeasure-0"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-0-BG001", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_0_BG001", "title": "Age, Continuous for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "status": "active", "statistic": [{"quantity": {"unit": "years", "value": 57.5}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"coding": [{"code": "STATO:0000573", "system": "https://fevir.net/sevco", "display": "mean"}]}, "attributeEstimate": [{"type": {"text": "Standard Deviation"}, "quantity": {"unit": "years", "value": 9.2}}]}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder", "reference": "#BG001"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Age, Continuous", "reference": "#NCT03421379-BaselineMeasure-0"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-0-BG002", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_0_BG002", "title": "Age, Continuous for Total at baseline in NCT03421379", "status": "active", "statistic": [{"quantity": {"unit": "years", "value": 50.2}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"coding": [{"code": "STATO:0000573", "system": "https://fevir.net/sevco", "display": "mean"}]}, "attributeEstimate": [{"type": {"text": "Standard Deviation"}, "quantity": {"unit": "years", "value": 13}}]}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Total", "reference": "#BG002"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Age, Continuous", "reference": "#NCT03421379-BaselineMeasure-0"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-1-BG000", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_1_BG000", "title": "Sex: Female, Male for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "Female"}, "quantity": {"unit": "Participants", "value": 13}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Male"}, "quantity": {"unit": "Participants", "value": 20}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution", "reference": "#BG000"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Sex: Female, Male", "reference": "#NCT03421379-BaselineMeasure-1"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-1-BG001", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_1_BG001", "title": "Sex: Female, Male for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "Female"}, "quantity": {"unit": "Participants", "value": 9}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Male"}, "quantity": {"unit": "Participants", "value": 30}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder", "reference": "#BG001"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Sex: Female, Male", "reference": "#NCT03421379-BaselineMeasure-1"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-1-BG002", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_1_BG002", "title": "Sex: Female, Male for Total at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "Female"}, "quantity": {"unit": "Participants", "value": 22}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Male"}, "quantity": {"unit": "Participants", "value": 50}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Total", "reference": "#BG002"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Sex: Female, Male", "reference": "#NCT03421379-BaselineMeasure-1"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-2-BG000", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_2_BG000", "title": "Ethnicity (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "Hispanic or Latino"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Not Hispanic or Latino"}, "quantity": {"unit": "Participants", "value": 33}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Unknown or Not Reported"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution", "reference": "#BG000"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Ethnicity (NIH/OMB)", "reference": "#NCT03421379-BaselineMeasure-2"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-2-BG001", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_2_BG001", "title": "Ethnicity (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "Hispanic or Latino"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Not Hispanic or Latino"}, "quantity": {"unit": "Participants", "value": 39}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Unknown or Not Reported"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder", "reference": "#BG001"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Ethnicity (NIH/OMB)", "reference": "#NCT03421379-BaselineMeasure-2"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-2-BG002", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_2_BG002", "title": "Ethnicity (NIH/OMB) for Total at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "Hispanic or Latino"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Not Hispanic or Latino"}, "quantity": {"unit": "Participants", "value": 72}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Unknown or Not Reported"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Total", "reference": "#BG002"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Ethnicity (NIH/OMB)", "reference": "#NCT03421379-BaselineMeasure-2"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-3-BG000", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_3_BG000", "title": "Race (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "American Indian or Alaska Native"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Asian"}, "quantity": {"unit": "Participants", "value": 33}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Native Hawaiian or Other Pacific Islander"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Black or African American"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "White"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "More than one race"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Unknown or Not Reported"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution", "reference": "#BG000"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Race (NIH/OMB)", "reference": "#NCT03421379-BaselineMeasure-3"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-3-BG001", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_3_BG001", "title": "Race (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "American Indian or Alaska Native"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Asian"}, "quantity": {"unit": "Participants", "value": 39}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Native Hawaiian or Other Pacific Islander"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Black or African American"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "White"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "More than one race"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Unknown or Not Reported"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder", "reference": "#BG001"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Race (NIH/OMB)", "reference": "#NCT03421379-BaselineMeasure-3"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-3-BG002", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_3_BG002", "title": "Race (NIH/OMB) for Total at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "American Indian or Alaska Native"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Asian"}, "quantity": {"unit": "Participants", "value": 72}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Native Hawaiian or Other Pacific Islander"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Black or African American"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "White"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "More than one race"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}, {"category": {"text": "Unknown or Not Reported"}, "quantity": {"unit": "Participants", "value": 0}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Count of Participants", "coding": [{"code": "STATO:0000047", "system": "https://fevir.net/sevco", "display": "count"}]}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Total", "reference": "#BG002"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Race (NIH/OMB)", "reference": "#NCT03421379-BaselineMeasure-3"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-4-BG000", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_4_BG000", "title": "Region of Enrollment for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "Japan"}, "quantity": {"unit": "participants", "value": 33}, "sampleSize": {"knownDataCount": 33}, "statisticType": {"text": "Number (see protocol for details)"}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution", "reference": "#BG000"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Region of Enrollment", "reference": "#NCT03421379-BaselineMeasure-4"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-4-BG001", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_4_BG001", "title": "Region of Enrollment for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "Japan"}, "quantity": {"unit": "participants", "value": 39}, "sampleSize": {"knownDataCount": 39}, "statisticType": {"text": "Number (see protocol for details)"}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder", "reference": "#BG001"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Region of Enrollment", "reference": "#NCT03421379-BaselineMeasure-4"}, "variableRole": "outcome"}]}, {"id": "NCT03421379-BaselineMeasure-4-BG002", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/non-comparative-evidence"]}, "name": "NCT03421379_BaselineMeasure_4_BG002", "title": "Region of Enrollment for Total at baseline in NCT03421379", "status": "active", "statistic": [{"category": {"text": "Japan"}, "quantity": {"unit": "participants", "value": 72}, "sampleSize": {"knownDataCount": 72}, "statisticType": {"text": "Number (see protocol for details)"}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "Baseline Reporting Population Description: All randomized participants who received at least one dose of study drug."}], "observed": {"type": "Group", "display": "Total", "reference": "#BG002"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Region of Enrollment", "reference": "#NCT03421379-BaselineMeasure-4"}, "variableRole": "outcome"}]}], "custodian": {"type": "Organization", "display": "Computable Publishing LLC", "reference": "Organization/118079"}, "relatesTo": [{"type": "cite-as", "targetMarkdown": "Baseline Characteristics Report for NCT03421379 [Database Entry: FHIR Composition Resource]. Contributors: [No author listed.] [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 399872. Revised 2025-12-11. Available at: https://fevir.net/resources/Composition/399872. Computable resource at: https://fevir.net/resources/Composition/399872#json."}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "399872", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "value": "NCT03421379-baseline-measure-report", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}], "resourceType": "Composition", "section": [{"code": {"text": "BaselinePopulationDescription"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">All randomized participants who received at least one dose of study drug.</div>", "status": "generated"}, "title": "Baseline Reporting Population Description"}, {"code": {"text": "BaselineGroupList"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">Glucagon Nasal Powder/Glucagon Hydrochloride Solution, Glucagon Hydrochloride Solution/Glucagon Nasal Powder, Total</div>", "status": "generated"}, "entry": [{"type": "Group", "display": "Glucagon Nasal Powder/Glucagon Hydrochloride Solution", "reference": "#BG000"}, {"type": "Group", "display": "Glucagon Hydrochloride Solution/Glucagon Nasal Powder", "reference": "#BG001"}, {"type": "Group", "display": "Total", "reference": "#BG002"}], "title": "Baseline Group List"}, {"code": {"coding": [{"code": "results", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Results"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Age, Continuous for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-0-BG000"}, {"type": "Evidence", "display": "Age, Continuous for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-0-BG001"}, {"type": "Evidence", "display": "Age, Continuous for Total at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-0-BG002"}], "focus": {"type": "EvidenceVariable", "display": "Age, Continuous", "reference": "#NCT03421379-BaselineMeasure-0"}, "title": "Age, Continuous"}, {"code": {"coding": [{"code": "results", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Results"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Sex: Female, Male for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-1-BG000"}, {"type": "Evidence", "display": "Sex: Female, Male for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-1-BG001"}, {"type": "Evidence", "display": "Sex: Female, Male for Total at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-1-BG002"}], "focus": {"type": "EvidenceVariable", "display": "Sex: Female, Male", "reference": "#NCT03421379-BaselineMeasure-1"}, "title": "Sex: Female, Male", "section": [{"code": {"text": "BaselineMeasureCalculatePct"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">False</div>", "status": "generated"}, "title": "Baseline Measure Calculate Percent"}]}, {"code": {"coding": [{"code": "results", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Results"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Ethnicity (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-2-BG000"}, {"type": "Evidence", "display": "Ethnicity (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-2-BG001"}, {"type": "Evidence", "display": "Ethnicity (NIH/OMB) for Total at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-2-BG002"}], "focus": {"type": "EvidenceVariable", "display": "Ethnicity (NIH/OMB)", "reference": "#NCT03421379-BaselineMeasure-2"}, "title": "Ethnicity (NIH/OMB)", "section": [{"code": {"text": "BaselineMeasureCalculatePct"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">False</div>", "status": "generated"}, "title": "Baseline Measure Calculate Percent"}]}, {"code": {"coding": [{"code": "results", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Results"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Race (NIH/OMB) for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-3-BG000"}, {"type": "Evidence", "display": "Race (NIH/OMB) for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-3-BG001"}, {"type": "Evidence", "display": "Race (NIH/OMB) for Total at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-3-BG002"}], "focus": {"type": "EvidenceVariable", "display": "Race (NIH/OMB)", "reference": "#NCT03421379-BaselineMeasure-3"}, "title": "Race (NIH/OMB)", "section": [{"code": {"text": "BaselineMeasureCalculatePct"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">False</div>", "status": "generated"}, "title": "Baseline Measure Calculate Percent"}]}, {"code": {"coding": [{"code": "results", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Results"}]}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>", "status": "empty"}, "entry": [{"type": "Evidence", "display": "Region of Enrollment for Glucagon Nasal Powder/Glucagon Hydrochloride Solution at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-4-BG000"}, {"type": "Evidence", "display": "Region of Enrollment for Glucagon Hydrochloride Solution/Glucagon Nasal Powder at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-4-BG001"}, {"type": "Evidence", "display": "Region of Enrollment for Total at baseline in NCT03421379", "reference": "#NCT03421379-BaselineMeasure-4-BG002"}], "focus": {"type": "EvidenceVariable", "display": "Region of Enrollment", "reference": "#NCT03421379-BaselineMeasure-4"}, "title": "Region of Enrollment"}]}